Translating the 2023 Malaysian Heart Failure Clinical Practice Guidelines (5th Edition) into primary care practice

Area of Science:

• Cardiology
• Public Health
• Clinical Practice Guidelines

Background:

• Heart failure (HF) presents a significant public health challenge in Malaysia, marked by rising prevalence and substantial morbidity and mortality.
• The 2023 Malaysian HF Clinical Practice Guidelines (CPGs) address these challenges with updated, evidence-based recommendations.
• These guidelines are specifically tailored for Malaysian primary care settings, focusing on long-term HF management.

Purpose of the Study:

• To provide a narrative review of the core recommendations in the 2023 Malaysian HF CPGs.
• To compare Malaysian CPG recommendations with international guidelines.
• To illustrate the practical application of these guidelines in primary care through case vignettes.

Main Methods:

• A narrative educational review summarizing the 2023 Malaysian HF CPGs.
• Comparative analysis of Malaysian CPGs against international guidelines.
• Case vignette illustrations for primary care application.

Main Results:

• The Malaysian CPGs utilize age-specific natriuretic peptide (NP) thresholds for improved diagnostic specificity.
• Diagnosis in resource-limited settings may rely on clinical assessment, ECG, and chest radiography.
• Emphasis is placed on early initiation and titration of foundational HF therapies in primary care.

Conclusions:

• Primary care physicians should initiate and titrate HF therapies early and ensure long-term adherence.
• Implementing NP testing, diastology studies, and structured titration protocols in primary care can enhance early diagnosis and therapy optimization.
• Systematic optimization of HF therapy is crucial for improving patient outcomes and preserving ventricular function.